Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A De Man

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Alimentary Pharmacology & Therapeutics|April 28, 2005
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuationM van Zonneveld, H J Flink, E Verhey, et al.
Lancet (London, England)|July 8, 1998
Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigenF ter Borg, F J ten Kate, H T Cuypers, et al.
Journal of Clinical Pathology|August 29, 2000
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individualsF ter Borg, F J ten Kate, H T Cuypers, et al.
British Journal of Clinical Pharmacology|February 6, 2018
Effects of training physicians in electronic prescribing in the outpatient setting on clinical, learning and behavioural outcomes: a cluster randomized trialF van Stiphout, J E F Zwart-van Rijkom, J Versmissen, et al.
The Netherlands Journal of Medicine|October 17, 2014
Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapyF A L M Eskens, K J van Erpecum, K P de Jong, et al.
Vaccine|May 26, 2009
Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work?R van Houdt, F D H Koedijk, S M Bruisten, et al.
Alimentary Pharmacology & Therapeutics|June 15, 2011
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromesA M C Baven-Pronk, M J Coenraad, H R van Buuren, et al.
Journal of Medical Virology|May 23, 2007
Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide surveyR van Houdt, S M Bruisten, F D H Koedijk, et al.
Oncogene|December 23, 2014
SMAD4 exerts a tumor-promoting role in hepatocellular carcinomaP Y Hernanda, K Chen, A M Das, et al.
The British Journal of Surgery|July 18, 2019
Safety and efficacy of transarterial embolization of hepatocellular adenomasB V van Rosmalen, A J Klompenhouwer, J Jaap de Graeff, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Alimentary Pharmacology & Therapeutics|April 28, 2005
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuationM van Zonneveld, H J Flink, E Verhey, et al.
Lancet (London, England)|July 8, 1998
Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigenF ter Borg, F J ten Kate, H T Cuypers, et al.
Journal of Clinical Pathology|August 29, 2000
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individualsF ter Borg, F J ten Kate, H T Cuypers, et al.
British Journal of Clinical Pharmacology|February 6, 2018
Effects of training physicians in electronic prescribing in the outpatient setting on clinical, learning and behavioural outcomes: a cluster randomized trialF van Stiphout, J E F Zwart-van Rijkom, J Versmissen, et al.
The Netherlands Journal of Medicine|October 17, 2014
Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapyF A L M Eskens, K J van Erpecum, K P de Jong, et al.
Vaccine|May 26, 2009
Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work?R van Houdt, F D H Koedijk, S M Bruisten, et al.
Alimentary Pharmacology & Therapeutics|June 15, 2011
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromesA M C Baven-Pronk, M J Coenraad, H R van Buuren, et al.
Journal of Medical Virology|May 23, 2007
Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide surveyR van Houdt, S M Bruisten, F D H Koedijk, et al.
Oncogene|December 23, 2014
SMAD4 exerts a tumor-promoting role in hepatocellular carcinomaP Y Hernanda, K Chen, A M Das, et al.
The British Journal of Surgery|July 18, 2019
Safety and efficacy of transarterial embolization of hepatocellular adenomasB V van Rosmalen, A J Klompenhouwer, J Jaap de Graeff, et al.
Pageof 17